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ABStrACt 
Rapid identification of microorganisms by the clinical microbiology laboratory is of crucial importance for optimal patients’ management 
and treatment. In general, bacterial identification by conventional methods requires 18-24 hours for colony isolation and at least 24 
additional hours for species identification. New technologies in microbiology have focused on the rapid diagnosis of bloodstream infections, 
since they are associated with high morbidity and mortality rates.
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introDuCtion
Clinical microbiology has developed continuously and there 
has been a constant search for new techniques and diagnostic 
methods with the aim to optimize the identification of pathogens. 
The rapid and accurate identification of infectious agents is of 
crucial importance in the clinical practice, mainly in serious 
infections such as blood stream infection (BSI), which may 
progress to sepsis/septic shock, with high morbidity and mortality 
rates. Projections have demonstrated that BSI incidence may rise 
by at least 10% annually in the next years, causing a major social 
and economic impact on the health care system(1, 3, 6-8, 15).
The accurate microorganism identification and the early 
introduction of an appropriate antimicrobial therapy are related 
to better clinical outcome of septic patients. According to Kumar 
et al.(19), the death risk increases by 7% after each hour between the 
beginning of the septic shock and the adjustment of antimicrobial 
therapy(19). Furthermore, other studies have substantiated the 
reduction in costs with the use of an appropriate antibiotic 
therapy(9, 14).
The most appropriate empirical antibiotic therapy must 
be selected based on the individual clinical case and take into 
consideration the epidemiological scenario present in each 
institution. An early approach is required in cases of sepsis/septic 
shock. In addition, a broad-spectrum antimicrobial therapy must be 
initiated and adjusted as soon as antimicrobial susceptibility testing 
results become available since increased chance of clinical success 
are associated with early adjustment of antimicrobial therapy(14).
Currently, after bloodculture positivity, the laboratory requires on 
average 1 hour to conduct bacterioscopy and release a partial result 
(Gram positive bacteria, Gram negative or yeast) and at least 18 hours 
for bacterial colony isolation. Final results require on average 24 to 
48 additional hours for completing identification and antimicrobial 
susceptibility tests. Additionally, only after this period the laboratory 
report is released and the antimicrobial therapy is adjusted(9). 
Therefore, new technologies are vital in order to reduce the 
time for bacterial identification. The advances in molecular 
biology methods have enabled the reduction in identification 
time and polymerase chain reaction (PCR) is one of the most 
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sensitive methods, which may be applied for the identification of 
slow growing and non-cultured microorganisms. Nevertheless, 
several identification tests based on PCR use the amplification of 
conserved genes such as those from the portion 16S of ribosomal 
deoxyribonucleic acid (rDNA). This technique normally requires 
the extraction of nucleic acids from bacterial colony isolates, 
which demands on average 24 to 36 hours. PCR conducted directly 
from clinical samples is usually restricted to specific samples such 
as spinal fluid, while as reaction inhibition may occur with some 
samples. Mass spectrometry has been commonly used by research 
laboratories and it is regarded as a promising technique as to the 
rapid identification of microorganisms (Figure 1).
figurE 1 –  Evolution of bacterial identification in the microbiology laboratory
rDNA: ribosomal deoxyribonucleic acid; MALDI-TOF MS: matrix assisted laser desorption/ionization-time of flight mass spectrometry. 
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Mass spectrometry applied to the identification of 
human pathogens
Mass spectrometry (MS) is another method that may be of 
great help to microbiological diagnosis. Furthermore, it has been 
widely used as a research tool, mainly in proteomic and lipid 
analyses. Several techniques based on ionization and subsequent 
biomolecular detection have been developed and the matrix assisted 
laser desorption/ionization-time of flight (MALDI-TOF) has been one 
of the mostly applied. It is a “mild” ionization technique, in which 
the formed ions have low internal energy, allowing the observation 
of ionized molecules with little or no fragmentation. Ion production 
from high molecular mass and non-volatile compounds such as 
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one, a microorganism colony is inoculated in the plate for mass 
spectrometry. In the latter, 1 µl of the extract is inoculated in the 
plate. There are several extraction protocols, either prescribed by 
MALDI-TOF MS manufacturers or published in the literature, 
which are specific for certain groups of microorganisms such as 
fungi and mycobacterium(12). Subsequently, 1 µl of the organic 
matrix, usually cinnamic acid, is added to the sample. Afterwards, the 
plate is positioned in the equipment for MALDI-TOF MS analysis 
(Figure 2). In all cases, it is recommended that the sample analysis 
should be carried out in duplicate. 
proteins has expanded the use of MS to several forms of molecules 
and study fields, mainly in the clinical microbiology laboratory. It 
is a rapid method for bacterial and fungal identification, with high 
accuracy and low operating costs(23, 26).
Fresh colonies (< 24h) are preferentially selected for 
performing bacterial identification by MALDI-TOF MS. However, 
it also can be accomplished using older colonies stored in air 
ambient. The identification may be conducted directly from the 
bacterial colonies or after total protein extraction. In the former 
figurE 2 –  Flowchart of the use of MALDI-TOF MS in microorganism identification at the clinical microbiology laboratory
MALDI-TOF MS: matrix assisted laser desorption/ionization-time of flight mass spectrometry; αCHCA: alpha-cyano-4-hydroxycinnamic acid. 
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The matrix allows that the proteins, non-volatile and 
thermally labile compounds, may be ionized and form intact ions 
in the gaseous phase. A laser beam, infrared or ultraviolet pulsed, 
serves as an ionization or desorption source. The matrix absorbs 
the laser energy, inducing the partial vaporization of the sample. 
As soon as the vaporization and ionization of molecules occur, they 
are transferred electrostatically to a mass spectrometer vacuum 
chamber. The ionized particles are formed and the migration of 
these particles is proportional to the ratio charge:mass, that is 
to say that minor ions reach a TOF detector before larger ions. 
The identification by MALDI-TOF MS is based on the score value 
released by the equipment. A higher or similar 2.3 value indicates 
that the identifications of genus and species are reliable. 2.0 to 
2.29 show that the genus is reliable and the species is probable. 1.7 
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to 1.99 values indicate that the identification of genus is probable. 
When score values are lower than 1.7, the equipment result 
is released as "not reliable", evincing that spectra acquisition 
was insufficient or no peak protein was detected, and further 
analyses are required for this sample. The optimal reproducibility 
in microbial identification by MALDI-TOF MS is based on the 
assessment of ribosomal proteins, which are commonly abundant 
in the cell. These proteins are part of the cell translational 
apparatus and are present in all living cells. Therefore, MALDI-
TOF MS is minimally influenced by environmental conditions or 
microorganism growth(23, 26, 29).
Currently, in Brazil, MS systems used for bacterial identification 
are available from two companies: the German Bruker Daltonics 
(Bremen, Germany) and the Japanese Shimadzu (Kyoto, Japan). 
Bruker mass spectrometer, Microflex LT (Linear TOF), is represented 
by BD Diagnostics (Becton, Dickinson and Company - Franklin Lakes, 
EUA), whereas Axima-Assurance from Shimadzu is commercialized 
by bioMérieux (Marcy lEtoile, France) as Vitek MS. The pieces of 
equipment from both manufacturers present the same principles, 
with relative differentiation in the number of spectra stored in their 
respective databases. Nonetheless, a study comparing both systems 
demonstrated that Bruker Daltonics mass spectrometer yields better 
results as to Gram positive bacteria in comparison with Shimadzu, 
whereas there was no significant difference as to Gram negative 
bacteria(5). In other two studies, similar results were observed for the 
identification of Gram positive and Gram negative bacteria when 
both  systems were compared(6, 22). 
One of the most significant points a to the success of this 
technique in microbiology laboratories is precisely the mass 
spectrometry database, which allows data interpretation. It is a 
fingerprinting of the microorganism in test. The main databases 
available for the identification of microorganisms are MALDI 
Biotyper - Bruker Daltonics (concept: Main Spectrum analyses) 
and AnagnosTec SARAMIS (Spectral ARchive And Microbial 
Identifications System) - bioMérieux (concept: Super Spectrum and 
Advanced Spectra Classifier [ASC]). 
The Biotyper system was conceived and marketed exclusively by 
Bruker Daltonics and is capable of analyzing specimens including 
bacterial, mycobacterial, and fungal samples in addition to samples 
recovered directly from positive blood culture bottles. The SARAMIS 
database was previously created and maintained by AnagnosTec 
GmbH prior to being purchased by bioMérieux for incorporation into 
the Vitek-MS platform. There is another database called Andromas 
system, utilized predominantly for clinical diagnostics in Europe and 
manufactured and maintained by Andromas SAS (Paris, France).
Some infrequent bacterial genera or environmental bacteria could 
not be identified by MALDI-TOF MS since their protein profiles are 
not included in the database. When the sample spectra is acquired by 
the system but not recognized by the database, it is possible to include 
its spectra into the individual database (library), but the operator 
must be responsible for providing or adding accurate information or 
data to the system. Thus, the inserted data should include reference 
strains or those whose identification has been confirmed by molecular 
biology techniques. MALDI Biotyper software allows the creation of a 
spectrum database different from that provided by the system. MALDI-
TOF MS databases may also be improved with updates offered by the 
manufacturers(12, 25).
In an investigation carried out by El Khéchine et al.(12), 
the authors created a local database, complementary to 
MALDI Biotyper 2.0 (Bruker Daltonics), with the most frequent 
mycobacterial species isolated in recent years within that 
geographic region. This database was established from previously 
stored samples: 11 mycobacterial strains including seven species 
from M. tuberculosis complex, 12 mycobacterial strains including 
11 species from M. avium complex and 20 mycobacterial strains 
including 16 species from non-tuberculosis mycobacteria (NTM). 
An original MALDI-TOF MS identification protocol was used for 
inactive mycobacteria. By applying this protocol in a standardized 
inoculum (at least 105 UFC/ml) and linking the databases, it was 
possible to identify 87 M. tuberculosis, 25 M. avium and 12 NTM 
isolates, with identification score ≥ 2 within merely 2.5 hours(12).
Although the inclusion of new protein spectra into MALDI-
TOF MS databases is an alternative to circumvent the problem of 
non-identified microorganisms, the recently developed software 
releases that probably will be available at clinical microbiology 
laboratories do not allow this insertion due to the new regulations 
introduced by the inspecting agencies. Therefore, periodic 
database updates provided by the manufactures are crucial for a 
wider coverage of the surveyed microorganisms.
Several studies that evaluated the performance of MALDI-
TOF MS in microorganism identification demonstrated that these 
systems are highly descriptive, accurate and reproducible. In a 
retrospective investigation carried out by Eigner et al.(11), 1,116 
clinical isolates were analyzed comparing Microflex LT (software 
MALDI-Biotyper 2.0 - Bruker Daltonics) with conventional 
biochemical identification. The study demonstrated a 95.2% 
consistency in the identification of bacterial species(11). In another 
research, Cherkaoui et al.(6) compared MALDI-TOF MS Microflex 
LT and Axima Assurance with automated and/or phenotypic 
methods. The sequencing of portion 16s rDNA was used as 
gold standard in order to clarify discrepant results among 
the methods. The authors analyzed 720 clinical isolates 
consecutively collected during laboratory routine. Microflex LT 
equipment identified 680 isolates (94.4%), from which 674 were 
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consistent with molecular and phenotypic tests, whereas Axima 
Assurance system identified 639 isolates (88.8%), from which 
635 were also consistent. The study concluded that if MALDI-
TOF MS had been applied as initial test and the biochemical 
identification had only been applied when there was no 
identification, the laboratory would have saved approximately 
US$5,00 per isolate and the time for result release would have 
been reduced to approximately 8 hours(6).
Investigations that made use of more recent databases reported 
approximately 100% identification of some microorganisms such 
as Neisseria spp.(18), Clostridium spp.(16), Mycobacterium spp.(25) 
and Salmonella spp.(10). Furthermore, MALDI-TOF MS method 
has been used in yeast identification(21). Marklein et al.(21) tested 
250 clinical isolates of Candida spp. from different body sites 
and 96% of the samples were accurately identified. Although the 
yeast results are promising, technical advances are still required 
for filamentous fungi such as Aspergillus spp., Penicillium spp. 
and Fusarium spp. 
Bacterial and yeast identification directly from 
clinical samples
The possibility of identifying pathogens directly from clinical 
samples such as urine or positive bloodculture has aroused great 
interest(20). The high concentration of proteins present in the 
blood and urine interferes in the detection of specific bacterial 
and fungal proteins, hence a major hindrance in the use of this 
method. Besides, the low inoculum of microorganisms present in 
the samples also hampers the identification of mass spectra. Thus, 
several research groups have developed and assessed different 
protocols for the extraction of proteins from microorganisms 
and removal of substances that may interfere in MALDI-TOF MS 
analysis(2, 13, 20, 28). These methods may be laborious and include 
several phases such as centrifugation, wash, gel separation and 
protein extraction. 
Studies on bacterial identification by MALDI-TOF MS, directly 
from positive bloodculture, have yielded better results in the 
identification of Gram negative organisms in comparison with 
Gram positive. Ferreira et al.(13) obtained an accurate bacterial 
identification of 83.3% Gram negative bacteria and 31.8% Gram 
positive bacteria(28) in comparison with conventional methods. 
In contrast, Moussaoui et al.(24) yielded better results with the 
accurate identification of 91.1% Gram negative and 89% Gram 
positive microorganisms through MALDI-TOF MS.
 Buchan et al.(2) evaluated 164 positive bloodculture 
samples with Sepsityper kit (Bruker Daltonics) for bacterial 
extraction. According to these authors, MALDI Sepsityper kit was 
able to identify 85.5% of isolates directly from monomicrobian 
bloodculture samples, with 97.6% genus consistency and 94.1% 
species consistency in comparison with other routine identification 
methods. Analyzing Gram negative microorganisms, 97.6% of 
tested samples reached a reliable confidence score (2.0). Analyzing 
Gram positive isolates, 80% presented acceptable score. However, 
when the analysis parameters of specific spectra for bloodculture 
were altered, there was an improvement in the identification of 
Gram positive samples (80% to 89%). The average identification 
time for MALDI-TOF biotyper/sepityper was 23 to 83 hours faster 
than other routine methods for the identification of Gram positive 
isolates and 34 to 51 hours for Gram negative isolates(2). Vlek 
et al.(29) demonstrated that bacterial identification by MALDI-TOF 
MS, directly from bloodculture, reduced the identification time in 
28.8 hours and it was associated with an increase of 11.3% in the 
number of patients that underwent suitable antimicrobial therapy 
34 hours after bloodculture positivity.
As to urine samples, Ferreira et al.(13) revealed a 93.1% 
consistency between MALDI-TOF MS identification and 
conventional methods. It is particularly worth mentioning that, 
although microorganism identification by MALDI-TOF MS directly 
from clinical samples is a promising method, the protocols still 
need to be improved. Moreover, the antimicrobial susceptibility 
tests are still required by conventional methods. 
MALDI-TOF MS applied to microbiological 
diagnostics: advantages and disadvantages
As it was discussed previously, the identification by MALDI-TOF 
MS is based on the analysis of protein spectrum from bacterial 
ribosome, therefore it is closely related to the analysis of gene 16S 
rDNA sequence. Nevertheless, due to the great similarity of these 
sequences in some species such as Shigella spp. and Escherichia 
coli or Streptococcus pneumoniae and other members of 
S. oralis/mitis group, sometimes there may be divergence in 
the identification among these species. Accordingly, standard 
biochemical tests such as antigen detection or molecular methods 
are required(30).
Other applications of MALDI-TOF MS are in development 
and the possibility of detecting bacterial resistance has aroused 
great interest. Several studies have demonstrated the detection of 
β-lactamase production in enterobacteria, the main mechanism 
of resistance to carbapenems and other β-lactam antibiotics(4, 17). 
The detection principle is based on the hydrolysis of β-lactam 
ring in presence of bacterial enzymes. MALDI-TOF MS technique 
is able to detect antibiotic mass alteration due to the chemical 
modification in the antimicrobial molecule. For this test, it 
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is necessary to incubate the bacterial protein extract with the 
antibiotic for a period of 1-4 hours so that it is possible to detect 
the presence of β-lactamase with hydrolytic activity on penicillins, 
cephalosporins and/or carbapenems(4, 27).
ConCLuSion
Within the past years, clinical microbiology laboratories 
experienced revolutionary changes in the way in which 
microorganisms are identified.
The major advantage of MALDI-TOF MS is the reliability as to 
the identification through the analysis of bacterial protein profile 
instead of physical, biochemical and metabolic differentiation. 
In comparison with conventional phenotypic methods or PCR, 
MALDI-TOF MS has been increasingly applied in the microbiology 
diagnostics and it has started to replace conventional biochemical 
methods in some laboratories worldwide. In Brazil, it is being 
tested by research labs and recently, Shimadzu system was 
approved for in vitro diagnostic (IVD) use, while Bruker system 
is waiting for ANVISA approval, scheduled for the second half of 
2013. In Europe, this technique has been used in microbiology 
clinical laboratories since 2009. MALDI-TOF MS has been recently 
introduced in diagnostic microbiology and several innovations 
and developments indicate its promising use in the future.
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rESuMo 
A rápida identificação de microrganismos no laboratório de microbiologia clínica é de extrema importância para direcionar o 
manejo e o tratamento de pacientes. Geralmente, a identificação bacteriana por métodos bioquímicos convencionais necessita de 
18 a 24 horas para o crescimento e o isolamento da colônia bacteriana e, pelo menos, 24 horas adicionais para a identificação da 
espécie. Novas tecnologias em microbiologia têm focado no desenvolvimento de métodos relacionados com o diagnóstico rápido 
das infecções da corrente sanguínea, uma vez que essas infecções são associadas à alta morbimortalidade.  
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